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Background: The purpose of this study was to determine the association of serum lactate dehydrogenase (LDH) 
levels with certain opportunistic infection and to determine an association between LDH levels and CD4+ 
lymphocyte counts. 
Methods: We studied 352 patients retrospectively with HIV infection and one of the following infections: 
histoplasmosis; toxoplasmosis; tuberculosis (pulmonary and disseminated); bacterial pneumonia; Pneurnocystis 
carinii pneumonia. Demographic and clinical data were obtained from the Adult Spectrum of Diseases (ASD) 
database in New Orleans. Bivariate and multivariate analysis were used to determine the association between LDH 
levels and opportunistic infections and CD4+ lymphocyte counts. 
Results: Patients with a serum LDH level ~225 IU/L had a mean CD4+ lymphocyte count of 159/dl (SE 19.3) as 
compared to patients with a serum LDH level 3225 IU/L, who had a mean CD4+ lymphocyte count of 58/dl (SE 
6.9) (PcO.01). Non-Caucasian race, a diagnosis of histoplasmosis, disseminated tuberculosis or Pneumocystis carinii 
pneumonia, and CD4+ lymphocyte count were significantly associated with a serum LDH level 3225 IU/L in the 
bivariate analysis. In a multivariate analysis, after controlling for race and CD4+ lymphocyte count, the only 
diagnoses that were significantly associated with the serum LDH level were definitive Pneumocystis carinii 
pneumonia and toxoplasmosis. Having a higher LDH level was not associated with early mortality. 
Conclusions: Although not diagnostic, serum LDH levels could be used as an adjunctive marker in certain 
opportunistic infections.There is an inverse relationship between serum LDH levels and CD4+ lymphocyte counts 
in this group. 
Int J Infect Dis 2002; 6: 178-181 
In patients with human immunodeficiency virus 
(HIV) infection, higher serum lactate dehydrogenase 
(LDH) levels have been associated with the presence 
of Pneumocystis carinii pneumonia (PCP),iA histo- 
plasmosis,5*6 tuberculosis,’ bacterial pneumonia,’ toxo- 
plasmosis,8,9 and lymphomas. l”,ll In PCP, higher lactate 
dehydrogenase (LDH) levels are associated with 
increased mortality, presumably attributable to the 
severity of the disease. It has been suggested that higher 
LDH levels correlate with the radiographic extent of the 
disease in patients with PCP and bacterial pneumonia, 
thus limiting the usefulness of this assay in differen- 
tiating between various pulmonary infecti0ns.i The 
purpose of this study was to determine the association 
of serum LDH levels with these opportunistic infections 
and HIV progression, as measured by CD4+ lympho- 
cyte counts. We also studied the effect of serum LDH 
levels on short-term mortality in these patients. 
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MATERIALS AND METHODS 
Study subjects were recruited from the Adult Spectrum 
of Disease database, a prospective study supported by 
the Center for Disease Control and Prevention, which 
examines the natural history of HIV infection in New 
Orleans, and through the microbiology laboratories of 
the Medical Center of Louisiana. Patients entered in the 
database between January 1,1989 and February 28,1998 
were reviewed (N=6216). Patients with diagnoses of 
PCP histoplasmosis, toxoplasmosis, bacterial pneumonia, 
and tuberculosis, who had a serum LDH level measured 
at the time of diagnosis, were included in this study. 
Because of a large number of patients with PCP, a 
random convenience sample was chosen with this 
diagnosis. These infections were chosen because they 
affect organs in the body with high LDH content, and 
tissue damage may potentially lead to higher serum 
LDH levels. Individuals with more than one of these 
diagnoses in a 6-month interval were excluded from 
the study. Other exclusion criteria were a diagnosis of 
viral hepatitis, known myocardial infarction, or cerebro- 
vascular accident. All diagnoses were defined according 
to the Center for Disease Control and Prevention 
guidelines.12 Bivariate analysis was used to evaluate the 
demographic and clinical characteristics associated with 
an elevated LDH level. Serum LDH ~225 IU/L was 
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defined as elevated, as this is the upper limit of normal 
reported by our laboratory. A logistic regression model 
for each diagnosis was used to determine which 
diagnoses were associated with higher LDH levels, after 
adjusting for variables found to be significant in the 
bivariate analysis, 
RESULTS 
A total of 352 subjects were included in the study.There 
were 30 patients with histoplasmosis (29 with dissemin- 
ated histoplasmosis as diagnosed by a positive culture or 
tissue stain from a site other than the sputum), 36 
patients with toxoplasmosis (all central nervous system 
disease), 109 patients with tuberculosis (pulmonary 90, 
disseminated 19) 57 patients with bacterial pneumonia, 
and 118 patients with PCP (presumptive 87, definitive 
31). Table 1 summarizes the characteristics of these 
patients.There were 125 patients with serum LDH level 
~225 IU/L with a mean CD4+ lymphocyte count of 
159/dl (SE=19.3), and 227 patients with serum LDH 
~225 IU/L with a mean CD4+ lymphocyte count of 
58/dl (SE=6.9) (PcO.01). Patients with a diagnosis of 
histoplasmosis or PCP (presumptive or definitive) were 
significantly more likely to have a serum LDH level 
~225 IU/L (PcO.01). In the multivariate analysis, after 
race and CD4+ lymphocyte counts had been controlled 
for, only two diagnoses were statistically associated with 
higher LDH level: Patients with toxoplasmosis had an 
adjusted odds ratio of 0.39 (95% CI 0.19, 0.79) while 
patients with definitive PCP had an odds ratio of 3.31 
(95% CI 1.12, 9.75) for having a higher serum LDH 
level (Table 2). A plot of mean LDH levels by CD4+ 
lymphocyte counts, stratified for race, showed that non- 
Caucasians were more likely to have a higher LDH 
level. In addition, a strong inverse relationship was seen 
between LDH levels and CD4+ lymphocyte counts. 
Higher serum LDH levels were not associated with a 
higher early mortality. 
DISCUSSION 
Elevated serum LDH levels have been associated 
with PCP, histoplasmosis, disseminated toxoplasmosis, 
tuberculosis, bacterial pneumonia, and lymphomas.l-l1 
In infections of the lung, LDH levels correlate with the 
extent of radiographic infiltrates rather than the 
underlying disease process. At least in PCP, serum LDH 
levels have prognostic significance, perhaps indicating 
the extent of lung injury. Elevated LDH levels have 
been seen in other infections involving the liver, e.g., 
viral hepatitis. Additionally, there are non-infectious 
causes of elevated serum LDH levels, including 
myocardial infarction and stroke. 
In PCP, serum LDH have been reported to range 
from 361 IU/L to as high as 1217 IU/L.lA Higher levels 
have been associated with higher mortality in several 
studies. In a study by Quist and Hill, patients with 
PCP had peak LDH levels of 547 IU/L and those with 
disseminated tuberculosis had peak levels of 569 IU/L.’ 
These were significantly higher than in those with pul- 
monary tuberculosis and bacterial pneumonia. Pugin 
Table 1. Characteristics of individuals with elevated vs non-elevated levels of LDH 
Sex 
Male 
Female 
Race 
Caucasian 
non-Caucasian 
Age at diagnosis 
<35 years 
235 years 
Mean CD4+ count at time of diagnosis 
Diagnosis 
histoplasmosis 
toxoplasmosis 
tuberculosis (disseminated) 
tuberculosis (pulmonary) 
pneumonia (bacterial) 
PCP (definitive) 
PCP (presumptive) 
Death within six months after diagnosis 
yes 
no 
*Statistically significant 
LDH ~225 U/L LDH 2225 U/L 
N= 125 N=227 
104 (83.2%) 189 (83.3%) 
21 (16.8%) 38 (16.7%) 
54 (43.2%) 74 (32.6%) 
71 (56.8%) 153 (67.4%) 
70 (56.0%) 123 (54.2%) 
55 (44.0%) 104 (45.8%) 
159.03 (SE = 19.3) 58.1 (SE=6.9) 
4 (3.2%) 26 (11.5%) 
18 (14.4%) 18 (7.9%) 
11 (8.8%) 8 (3.5%) 
39 (31.2%) 51 (22.5%) 
25 (20.0%) 32 (14.1%) 
4 (3.2%) 29 (12.8%) 
24 (19.2%) 63 (27.8%) 
32 (25.6%) 70 (30.8%) 
93 (74.4%) 157 (69.2%) 
P-value 
>0.90 
cO.05” 
co.75 
co.01 * 
<0.01* 
>0.90 
co.35 
co.10 
co.20 
co.01 * 
co.01 * 
10.35 
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and others reported nine patients with disseminated 
toxoplasmosis with a median LDH level of 10,222 IIJ/L, 
while eight patients with cerebral toxoplasmosis had a 
median level of 475 IU/L.s In another study, nine patients 
with septic shock from disseminated toxoplasmosis had 
a mean serum LDH level of 6510 IU/L.9 Markedly 
elevated serum LDH levels may also be a clue to the 
diagnosis of histoplasmosis in certain clinical settings.596 
Serum LDH levels are also an independent prognostic 
factor in HIV-associated non-Hodgkin’s lymphoma.lO,rl 
In a retrospective review of 200 HIV infected 
patients, those with a serum LDH level above the upper 
limit of normal for their laboratory had a significantly 
greater chance of fulfilling criteria for acquired immuno- 
deficiency syndrome (AIDS) and having a lower CD4-t 
lymphocyte count. l3 They were also more likely to have 
a diagnosis of PCP, bacterial pneumonia, disseminated 
cytomegalovirus disease, and Mycobacterium avium 
complex infection. While there is an established associ- 
ation between serum LDH level and various HIV- 
related diagnoses, the association with level of immuno- 
suppression is not well characterized. An association 
between LDH isoenzymes and CD4/CD8+ lymphocyte 
count has been reported with suggestions that LDH 
isoenzyme activity may be useful in monitoring disease 
activity in children. l4 In our analysis patients with histo- 
plasmosis and presumptive and definitive PCP were 
more likely to have an elevated serum LDH level. After 
controlling for race and CD4+ lymphocyte count, only 
definitive PCP was associated with higher serum LDH 
level. Interestingly, patients with a diagnosis of toxo- 
plasmosis were less likely to have an elevated serum 
LDH level. 
Limitations of our study include its retrospective 
data gathering and a convenience sample taken from the 
Adult Spectrum of Disease (ASD) database. In addition 
there was a wide range of serum LDH levels in patients 
with disseminated histoplasmosis. The measurement of 
serum LDH was not done in a controlled study setting, 
and timing of specimen collection was not always 
uniform in relation to the diagnosis of the opportunistic 
infection studied. In spite of these limitations, we feel 
that our observations support our conclusions. 
Table 2. Adjusted odds ratios for diagnoses predicting an 
elevated serum lactate dehydrogenase level (adjusted for 
race and CD4+ lymphocyte count) 
Diagnosis 
Histoplasmosis 
Toxoplasmosis 
Tuberculosis (disseminated) 
Tuberculosis (pulmonary) 
Bacterial pneumonia 
PCP (definitive) 
PCP (presumptive) 
*Statistically significant. 
Odds ratio 95% Cl 
2.72 0.92, 8.10 
0.39 0.19, 0.79* 
0.46 0.17, 1.23 
0.80 0.47, 1.36 
1.22 0.62, 2.39 
3.31 1.12, 9.75* 
1.12 0.64, 1.97 
In conclusion, serum LDH level may serve as a 
useful adjunctive marker in certain HIV-associated 
condition. Markedly elevated levels should alert the 
physician to the possibility of certain diagnoses in 
appropriate clinical settings. Such elevations and 
associations should, however, be interpreted with 
caution because they are not diagnostic in themselves. 
A direct relationship between serum LDH level and 
disease activity or severity does not always exist, as 
serum LDH level may be affected by the degree of 
immunosuppression itself, as measured by the CD4+ 
lymphocyte count. More studies are needed to establish 
the role of CD4+ lymphocyte count and immuno- 
suppression in elevated serum LDH levels in HIV 
infected patients. 
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